Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.57
0.564.30%
At close: -
$13.45
-0.12-0.88%
After Hours: 4:03 PM EDT
Comments
Loading...
Integra Lifesciences Analyst Ratings and Price Targets | NASDAQ:IART | Benzinga
Integra Lifesciences Holdings Corp has a consensus price target of $29.36 based on the ratings of 13 analysts. The high is $53 issued by Jefferies on July 12, 2023. The low is $12 issued by JP Morgan on May 6, 2025. The 3 most-recent analyst ratings were released by JMP Securities, JP Morgan, and Wells Fargo on May 9, 2025, May 6, 2025, and May 6, 2025, respectively. With an average price target of $16.67 between JMP Securities, JP Morgan, and Wells Fargo, there's an implied 23.92% upside for Integra Lifesciences Holdings Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
JP Morgan
Wells Fargo
Truist Securities
Citizens Capital Markets
1calculated from analyst ratings
Analyst Ratings for Integra Lifesciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2025 | Buy Now | 85.87% | JMP Securities | David Turkaly46% | $35 → $25 | Maintains | Market Outperform | Get Alert |
| 05/06/2025 | Buy Now | -10.78% | JP Morgan | Robbie Marcus63% | $24 → $12 | Maintains | Underweight | Get Alert |
| 05/06/2025 | Buy Now | -3.35% | Wells Fargo | Vik Chopra46% | $25 → $13 | Maintains | Equal-Weight | Get Alert |
| 04/11/2025 | Buy Now | 41.26% | Truist Securities | Richard Newitter74% | $26 → $19 | Maintains | Hold | Get Alert |
| 03/31/2025 | Buy Now | — | Argus Research | David Toung69% | — | Upgrade | Hold → Buy | Get Alert |
| 02/26/2025 | Buy Now | 160.22% | Citizens Capital Markets | David Turkaly46% | $35 → $35 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/05/2024 | Buy Now | 63.57% | Citigroup | Joanne Wuensch75% | $16 → $22 | Maintains | Sell | Get Alert |
| 10/14/2024 | Buy Now | 56.13% | Truist Securities | Richard Newitter74% | $26 → $21 | Maintains | Hold | Get Alert |
| 10/07/2024 | Buy Now | 33.83% | B of A Securities | Craig Bijou77% | $26 → $18 | Maintains | Underperform | Get Alert |
| 10/07/2024 | Buy Now | — | BTIG | Ryan Zimmerman74% | — | Upgrade | Sell → Neutral | Get Alert |
| 10/01/2024 | Buy Now | 18.96% | Citigroup | Joanne Wuensch75% | $20 → $16 | Maintains | Sell | Get Alert |
| 08/28/2024 | Buy Now | 48.7% | BTIG | Ryan Zimmerman74% | $22 → $20 | Maintains | Sell | Get Alert |
| 08/22/2024 | Buy Now | 48.7% | Citigroup | Joanne Wuensch75% | $23 → $20 | Maintains | Sell | Get Alert |
| 07/30/2024 | Buy Now | 160.22% | JMP Securities | David Turkaly46% | $40 → $35 | Maintains | Market Outperform | Get Alert |
| 07/30/2024 | Buy Now | 93.31% | Truist Securities | Richard Newitter74% | $32 → $26 | Maintains | Hold | Get Alert |
| 07/30/2024 | Buy Now | 71% | Citigroup | Joanne Wuensch75% | $30 → $23 | Downgrade | Neutral → Sell | Get Alert |
| 07/30/2024 | Buy Now | 63.57% | BTIG | Ryan Zimmerman74% | → $22 | Downgrade | Neutral → Sell | Get Alert |
| 07/16/2024 | Buy Now | 137.92% | Truist Securities | Richard Newitter74% | $25 → $32 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 100.74% | Morgan Stanley | Drew Ranieri47% | $24 → $27 | Maintains | Underweight | Get Alert |
| 07/10/2024 | Buy Now | 123.05% | Citigroup | Joanne Wuensch75% | $28 → $30 | Maintains | Neutral | Get Alert |
| 05/22/2024 | Buy Now | 108.18% | Citigroup | Joanne Wuensch75% | $24 → $28 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | 78.44% | Morgan Stanley | Drew Ranieri47% | $37 → $24 | Maintains | Underweight | Get Alert |
| 05/07/2024 | Buy Now | 197.4% | JMP Securities | David Turkaly46% | $49 → $40 | Maintains | Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 85.87% | Wells Fargo | Vik Chopra46% | $45 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/07/2024 | Buy Now | 85.87% | Truist Securities | Richard Newitter74% | $37 → $25 | Maintains | Hold | Get Alert |
| 05/07/2024 | Buy Now | 93.31% | B of A Securities | Craig Bijou77% | $42 → $26 | Maintains | Underperform | Get Alert |
| 04/03/2024 | Buy Now | 182.53% | Citigroup | Joanne Wuensch75% | $38 → $38 | Upgrade | Sell → Neutral | Get Alert |
| 03/01/2024 | Buy Now | 204.83% | Truist Securities | Richard Newitter74% | $46 → $41 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 264.31% | JMP Securities | David Turkaly46% | $55 → $49 | Maintains | Market Outperform | Get Alert |
| 12/22/2023 | Buy Now | 242.01% | Truist Securities | Richard Newitter74% | $44 → $46 | Maintains | Hold | Get Alert |
| 12/14/2023 | Buy Now | 308.92% | JMP Securities | David Turkaly46% | $55 → $55 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/14/2023 | Buy Now | 227.14% | Truist Securities | Richard Newitter74% | $39 → $44 | Maintains | Hold | Get Alert |
| 12/05/2023 | Buy Now | 264.31% | Wells Fargo | Larry Biegelsen35% | $40 → $49 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/14/2023 | Buy Now | 271.75% | CL King | Kristen Stewart49% | → $50 | Initiates | → Buy | Get Alert |
| 10/26/2023 | Buy Now | 189.96% | Truist Securities | Richard Newitter74% | $41 → $39 | Maintains | Hold | Get Alert |
| 10/26/2023 | Buy Now | 175.09% | Morgan Stanley | Drew Ranieri47% | $44 → $37 | Maintains | Underweight | Get Alert |
| 08/24/2023 | Buy Now | 227.14% | Morgan Stanley | Drew Ranieri47% | → $44 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/28/2023 | Buy Now | 346.1% | JMP Securities | David Turkaly46% | $65 → $60 | Maintains | Outperform | Get Alert |
| 07/19/2023 | Buy Now | 256.88% | Truist Securities | Richard Newitter74% | $44 → $48 | Maintains | Hold | Get Alert |
| 07/12/2023 | Buy Now | 294.05% | Jefferies | Matthew Taylor69% | $58 → $53 | Upgrade | Hold → Buy | Get Alert |
| 06/08/2023 | Buy Now | — | Argus Research | David Toung69% | — | Downgrade | Buy → Hold | Get Alert |
| 05/31/2023 | Buy Now | 219.7% | Morgan Stanley | Drew Ranieri47% | $59 → $43 | Maintains | Equal-Weight | Get Alert |
| 05/30/2023 | Buy Now | 227.14% | Truist Securities | Richard Newitter74% | $54 → $44 | Reiterates | Hold → Hold | Get Alert |
| 05/26/2023 | Buy Now | 383.27% | JMP Securities | David Turkaly46% | → $65 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/24/2023 | Buy Now | 219.7% | JP Morgan | Robbie Marcus63% | $56 → $43 | Downgrade | Neutral → Underweight | Get Alert |
| 05/23/2023 | Buy Now | 189.96% | Citigroup | Joanne Wuensch75% | $59 → $39 | Downgrade | Neutral → Sell | Get Alert |
| 05/18/2023 | Buy Now | 301.49% | Truist Securities | Richard Newitter74% | $58 → $54 | Maintains | Hold | Get Alert |
| 04/27/2023 | Buy Now | 383.27% | JMP Securities | David Turkaly46% | $75 → $65 | Maintains | Outperform | Get Alert |
| 04/17/2023 | Buy Now | 360.97% | Truist Securities | Richard Newitter74% | $58 → $62 | Maintains | Hold | Get Alert |
| 02/23/2023 | Buy Now | 338.66% | Citigroup | Joanne Wuensch75% | $60 → $59 | Maintains | Neutral | Get Alert |
| 01/06/2023 | Buy Now | 338.66% | Morgan Stanley | Drew Ranieri47% | $50 → $59 | Maintains | Equal-Weight | Get Alert |
| 12/20/2022 | Buy Now | 331.23% | Truist Securities | Richard Newitter74% | $52 → $58 | Maintains | Hold | Get Alert |
| 12/12/2022 | Buy Now | 346.1% | Citigroup | Joanne Wuensch75% | $50 → $60 | Maintains | Neutral | Get Alert |
| 10/27/2022 | Buy Now | 457.62% | JMP Securities | David Turkaly46% | $85 → $75 | Maintains | Market Outperform | Get Alert |
| 10/27/2022 | Buy Now | 271.75% | Morgan Stanley | Drew Ranieri47% | $49 → $50 | Maintains | Equal-Weight | Get Alert |
| 10/26/2022 | Buy Now | 286.62% | Truist Securities | Richard Newitter74% | $46 → $52 | Maintains | Hold | Get Alert |
| 10/17/2022 | Buy Now | 242.01% | Truist Securities | Richard Newitter74% | $60 → $46 | Maintains | Hold | Get Alert |
| 10/12/2022 | Buy Now | 256.88% | Jefferies | Matthew Taylor69% | → $48 | Initiates | → Hold | Get Alert |
| 10/11/2022 | Buy Now | 264.31% | Morgan Stanley | Drew Ranieri47% | $58 → $49 | Maintains | Equal-Weight | Get Alert |
| 08/25/2022 | Buy Now | 331.23% | Morgan Stanley | Drew Ranieri47% | $59 → $58 | Maintains | Equal-Weight | Get Alert |
| 07/25/2022 | Buy Now | 338.66% | Morgan Stanley | Drew Ranieri47% | → $59 | Initiates | → Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | 316.36% | Truist Securities | Richard Newitter74% | $70 → $56 | Maintains | Hold | Get Alert |
| 05/17/2022 | Buy Now | 398.14% | Citigroup | Joanne Wuensch75% | $70 → $67 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Integra Lifesciences (IART) stock?
The latest price target for Integra Lifesciences (NASDAQ:IART) was reported by JMP Securities on May 9, 2025. The analyst firm set a price target for $25.00 expecting IART to rise to within 12 months (a possible 85.87% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Integra Lifesciences (IART)?
The latest analyst rating for Integra Lifesciences (NASDAQ:IART) was provided by JMP Securities, and Integra Lifesciences maintained their market outperform rating.
When was the last upgrade for Integra Lifesciences (IART)?
The last upgrade for Integra Lifesciences Holdings Corp happened on March 31, 2025 when Argus Research raised their price target to N/A. Argus Research previously had a hold for Integra Lifesciences Holdings Corp.
When was the last downgrade for Integra Lifesciences (IART)?
The last downgrade for Integra Lifesciences Holdings Corp happened on July 30, 2024 when Citigroup changed their price target from $30 to $23 for Integra Lifesciences Holdings Corp.
When is the next analyst rating going to be posted or updated for Integra Lifesciences (IART)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Integra Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Integra Lifesciences was filed on May 9, 2025 so you should expect the next rating to be made available sometime around May 9, 2026.
Is the Analyst Rating Integra Lifesciences (IART) correct?
While ratings are subjective and will change, the latest Integra Lifesciences (IART) rating was a maintained with a price target of $35.00 to $25.00. The current price Integra Lifesciences (IART) is trading at is $13.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
